CALL US NOW (952) 943-3937
DONATE NOW

Tagged as: LEXI REED HOLTUM

committee testimony

FDA Committee Votes Against Approval of New Opioid

On June 26, advocates of the Steve Rummler HOPE Network testified to an FDA panel opposing the approval of a powerful new extended-release opioid, Remoxy™. Executive Director, Lexi Reed Holtum was joined by board member, Michael Daub and medical advisory committee member, Dr. Andrew Kolodny. The FDA advisory committee voted

Read More

NEWSLETTER SIGN-UP

Stay up to date with the Steve Rummler HOPE Network.